Bicycle Therapeutics (BCYC)

NASDAQ: BCYC · Real-Time Price · USD

9.33

0.25 (2.75%)

At close: May 02, 2025, 12:06 PM

Bicycle Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Net Income	-169.03M	-180.66M	-112.72M	-66.82M	-51.01M	-30.61M	-21.85M	-16.26M	-13.51M
Depreciation & Amortization	7.17M	6.55M	3.69M	1.41M	1.28M	960K	712K	332K	269.29K
Stock-Based Compensation	38.08M	32.48M	26.78M	12.08M	6.51M	3.08M	1.02M	515K	123K
Other Working Capital	-36.56M	66.45M	-248K	37.12M	24M	-10M	-3.95M	12.96M	1.37M
Other Non-Cash Items	-2.26M	734.03K	442K	2.14M	751K	5.38M	665K	856K	182.52K
Deferred Income Tax	-5.23M	3.32M	-4.98M	-1.67M	-673K	n/a	n/a	119K	n/a
Change in Working Capital	-33.46M	76.96M	672K	38.06M	25.35M	-7.43M	-6.63M	13.02M	1.85M
Operating Cash Flow	-164.72M	-60.63M	-86.11M	-14.79M	-17.79M	-28.61M	-26.08M	-1.42M	-11.27M
Capital Expenditures	-1.24M	-2.93M	-18.99M	-2.03M	-1.2M	-1.55M	-1.19M	-1.11M	-243.36K
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	-1.24M	-2.93M	-18.99M	-2.03M	-1.2M	-1.55M	-1.19M	-1.11M	-243.36K
Debt Repayment	-31.91M	n/a	n/a	15M	15M	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	-576K	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	7.53M	682K	989K	7.18M	-301K	149K	1K	1K	16.77M
Financial Cash Flow	519.75M	250.03M	6.69M	320.73M	62.84M	58.44M	25.43M	57.88M	16.77M
Net Cash Flow	353.1M	187.82M	-99.53M	302.69M	43.87M	28.74M	-4.28M	58.26M	3.46M
Free Cash Flow	-165.96M	-63.56M	-105.1M	-16.82M	-18.99M	-30.17M	-27.26M	-2.53M	-11.51M